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The study explores the inhibition effects of MicroRNAs in osteosarcoma, as a means of suggesting it as treatment for bone 
cancer. MicroRNAs (miRNAs) are a sort of noncoding RNA molecules that regulates gene expression by targeting mRNAs and 
play critical roles in tumor development. This study probed the effect of miR-9-5p on osteosarcoma development. Human 
osteosarcoma cell lines U2-OS, 143B, MG63 and HOS and normal human osteoblast cell line hFOB were cultivated and 
expression of miR-9-5p and Grb2-associated binding protein 2 (Gab2) measured. The binding of miR-9-5p and Gab2 was 
confirmed using a bio-information program and dual luciferase reporter gene assay. Loss-of-functions of miR-9-5p and Gab2 were 
performed to measure their roles in osteosarcoma cell proliferation, invasion, migration and resistance to death. Result showed high 
miR-9-5p expression and low Gab2 expression in osteosarcoma cells, particularly in U2-OS cells. miR-9-5p directly bound to the 
3untranslated region of Gab2. Down-regulated miR-9-5p induced U2-OS cell proliferation, invasion and the resistance to death, 
while conversely, silenced Gab2 led to an opposite trend on U2-OS cell growth and metastasis. Moreover, co-effect of inhibited 
miR-9-5p and silenced Gab2 led to decreased cell proliferation but promoted cell apoptosis compared to inhibited miR-9-5p alone, 
while it led to enhanced cell proliferation and invasion, but reduced cell apoptosis compared to silenced Gab2 alone. To conclude, 
this study demonstrated that miR-9-5p could inhibit osteosarcoma cell proliferation, invasion, migration and resistance to death via 
negatively targeting Gab2. 
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Osteosarcoma is the most prevalent primary bone tumor 
and the third widespread tumor in children and young 
teenagers
1
. It is featured with quick development, great 
metastatic possibility, and unfavorable clinical 
prognosis
2
. To date, systemic chemotherapy and local 
control surgery remain the major treatments for 
osteosarcoma
3
. Despite advances in the treating options, 
the overall survival rate of osteosarcoma patients has not 
been considerably enhanced yet
4
. Nearly 30–40% of 
localized osteosarcoma patients develop recurrent or 
metastatic diseases, and in such cases, the average 
survival time will be reduced to no more than one year
5
. 
Thus, identifying novel molecules participating in tumor 
development is crucial to decrease the incidence and 
mortality of this malignant disease. 
MicroRNAs (miRNAs) are a family of short 
noncoding RNAs molecules composed of 20-25 
nucleotides that work as negative regulators of the 
expression of post-transcription gene via binding to the 
3untranslated region (3UTR) of target mRNAs thus 
contributing to transcript decline
6,7
. They have emerged 
as prospective diagnostic and therapeutic options owing 
to their correlation with tumorigenesis, survival, and 
prognosis
8
. Abnormal expression of miRNAs has been 
documented in multiple pathological conditions 
including solid tumors indicating their participance in 
carcinogenesis
9
. Among them, miR-9-5p has been 
documented to work either as a tumor-inhibitor in several 







, or as a tumor-





. While the role of miR-9-5p in 
osteosarcoma remains unidentified. Gab2 has been 
frequently detected in several human cancers
15-17
. For 
instance, Gab2 overexpression was found in ovarian 
cancer, and its overexpression increased the formation of 
tumor sphere in ovarian cancer cells
18
. Importantly, a 
previous study suggested that Gab2 is over-expressed in 
human osteosarcoma cells
19
. Hence, this study 
hypothesized that miR-9-5p could directly target Gab2 
and inhibit the osteosarcoma development. 
 
Materials and Methods 
Cell culture and transfection 
Human osteosarcoma cell lines U2-OS, 143B, 








line hFOB purchased from ATCC (Manassas, VA, 
USA) were cultivated in DMEM supplemented with  
10% fetal bovine serum (FBS), 100 μg/mL 
streptomycin and 100 U/mL penicillin in a 37C 
incubator with 5% CO2. Cells were passaged once the 
cell reached 80% of confluence. Next, the cells were 
randomly assigned into control, inhibitor negative 
control (NC), miR-9-5p inhibitor, small interfering-
Gab2 (si-Gab2) group, miR-9-5p inhibitor + si-Gab2 
groups after corresponding transfections. All the 
transfections were conducted as per the instructions  
of Lipofectamine RNAiMax Transfection Reagent 
(Invitrogen Inc., Carlsbad, CA, USA). The miR-
inhibitor, miR-NC and siRNA plasmids were all 
purchased from Guangzhou RiboBio Co., Ltd 
(Guangzhou, Guangdong China). In brief, 50 nM 
plasmid was added into 100 μL serum-free Opti-
MEM medium (Gibco Company, Grand Island, NY, 
USA) and further fixed with 1 μL RNAiMax. The 
mixture stood at room temperature (25C) for 10 min 
and then seeded into 24-well plates, after which the 
cell suspension was added to the plates and cultured at 
37C with 5% CO2 for 72 h, and then the cells were 
collected for following experiments. 
 
Dual luciferase reporter gene assay 
Dual luciferase reporter gene assay was performed 
as described by Ting et al. with adjustments
20
. The 
binding sites of miR-9-5p and Gab2 was initially 
predicted on an online program Target scan 
(http://www.targetscan.org), and the binding relation 
was further identified using dual luciferase reporter 
gene assay. The synthetic Gab2 (Gab2-WT) or Gab2 
mutant-type (Gab2-Mut) sequences were and cloned 
to the upstream of firefly luciferase gene to produce 
pMIR-Gab2-WT and pMIR-Gab2-Mut luciferase 
reporter plasmids. Well-designed pMIR-based 
reporter plasmids along with either miRNA-9-3p 
mimic or mimic NC were co-transfected into 
HEK293T cells with pMIR-renilla luciferase used as 
an internal reference. Cells were lysed 48 h after 
transfections. Relative luciferase activity was 
evaluated with the dual-luciferase reporter assay 
system as per the kit’s instructions (E1910, Promega 
Corp., Madison, Wisconsin, USA). In brief, 5 μL 
firefly luciferase buffer along with 5 μL substrate or 
5 μL renilla luciferase buffer along with 5 μL 
substrate was added to detect the corresponding 
luciferase activities. The relative value of firefly 
luciferase activity/renilla luciferase activity was 
evaluated and analysed. 
Reverse transcription-quantitative polymerase chain reaction 
(RT-qPCR) 
This was performed as described by Crookenden et al. 
with little modifications
21
. Total RNA from cells was 
extracted using Trizol (Invitrogen), and the RNA 
concentration was detected using Bio-Rad analyzer, 
after which 1 μg RNA was reversely transcribed to 
cDNA using a cDNA Reverse Transcription Kit 
(Thermo Fisher Scientific Inc., Waltham, MA, USA). 





 (TliRNase H Plus) assay kit (Takara 
Holdings Inc., Kyoto, Japan) on an ABI7500 qPCR kit 
(Thermo Fisher). The PCR condition (20 μL) was  
10 min of pre-denaturation at 95°C, followed by 40 
cycles of denaturation (95°C for 15 s), annealing (60°C 
for 60 s) and a final extension (72°C for 40 s). U6 was 
set as an internal reference for miR-9-5p while GAPDH 
was set as an internal reference for other genes. The  
2
-ΔΔCt
 method was applied in which ΔΔCt refers to the 
ratio of the target gene expression between the 
experimental and the control groups (Table 1). 
 
Western blot analysis 
Western blot analysis was performed as described by 
Zhaowei et al. with slight modification
22
. Forty-eight 
hours after transfection, cells were lysed with Radio-
Immunoprecipitation assay (RIPA) lysis buffer and then 
the total proteins were collected, and the protein 
concentration was evaluated via a BCA kit (P0012, 
Beyotime Biotechnology Co., Ltd, Shanghai, China). 
Extracted proteins were run on 10% SDS-PAGE and 
then transferred to polyvinylidene difluoride (PVDF) 
membranes (Merck Millipore Corp., Billerica, MA, 
USA). Next, the membranes were sealed with 5% 
bovine serum albumin (BSA) at room temperature for  
1 h and washed with TBST (tris-buffered saline + 0.1% 
Tween 20), and then incubated with following primary 
antibodies at 4°C overnight: Gab2 rabbit antibody 
Table 1 — Primer sequences of RT-qPCR 



















Note: F, forward; R, reverse 




(1:1000, 3239, Cell Signaling Technology (CST), 
Beverly, MA, USA), matrix metalloproteinase-2 rabbit 
antibody (MMP-2, 1:1000, 40994, CST), MMP-9 rabbit 
antibody (1:1000, 13667, CST). Next, the membranes 
were washed in a shaker containing TBST for 3 times 
(10 min each time). Thereafter, the membranes were 
incubated with horseradish peroxidase-labelled goat-anti 
rabbit and goat-anti mouse secondary antibodies 
(1:10000, Jackson, USA) for 1 h at room temperature, 
and washed 3 times with TBST (15 min each time). 
After that, the membranes were taken out and the 
remaining liquid was absorbed by filter papers. Then, 
the membranes were added with Pro-light horseradish 
peroxidase chemoluminescence reagent (PA112, 
TianGen Biotech Co., Ltd. Beijing, China) and covered 
with cling films, after which they were exposed, 
visualized and fixed in the dark, and then the bands were 
analysed using an Image J software (National Institutes 
of Health, Bethesda, Maryland, USA). 
 
Cell-Counting Kit-8 (CCK8) method 
The U2-OS cells in each group were trypsinized 
with the cell suspension adjusted to suitable 
concentration and seeded into 96-well plates at the 
density of 200 μL per well. Three duplicated wells 
were set for each group and another well added with 
medium only was set as control. The optical density 
(OD) values of cells were measured at 0 h, 24 h, 34 h 
and 72 h as per the instructions of the CCK-8 reagent 
(C0038, Beyotime Biotechnology Co., Ltd, Shanghai, 
China). In brief, the supernatant was discarded, and 
each well was added with 100 μL serum-free medium 
and 100 μL CCK-8 reagent. the OD 450 nm values of 
cells were measured following 1-4 h of incubation. 
 
Flow cytometry 
Flow cytometry was performed as described by 
Danylovych et al.
23
. Forty-eight hours after transfection, 
cells in each group were successively detached with 
ethylene diamine tetraacetic acid-free trypsin, washed 
with phosphate buffer saline (PBS) for twice, 
centrifuged at 1000 g for 5 min and then collected for 
follow-up experiments. Cell apoptosis was measured as 
per the instructions of the AnnexinV-fluorescein 
isothiocyanate (FITC) assay kit (GK3603, Beijing 
Dingguo Changsheng Biotechnology Co., Ltd, Beijing, 
China). The cells were resuspended with PBS and 
counted, and then approximately 10
5
 cells were 
harvested and suspended with 500 μL binding buffer, 
which was followed by mixing 5 μL Annexin V-FITC 
and 5 μL propidium iodide (PI) and 10 min of reaction 
at room temperature in dark condition. Next, the cell 
apoptosis was measured using a flow cytometer. The 
green fluorescence of Annexin V-FITC was observed in 
channel FL1 while the red fluorescence of PI was 
observed in channel FL3. The cell cycle assay kit 
(C1052) was purchased from Beyotime. Collected cells 
were washed twice with ice-cold PBS, fixed with 1 mL 
cold 75% ethanol (−20C), and incubated at 4C for 2 h 
or overnight. After that, the cells were rinsed twice with 
cold PBS and added with 500 μL PI staining solution 
(prepared according to the instructions). Then the cells 
were resuspended and warm-bathed at 37C for 30 min 
in dark condition, after which the cell cycle was 
measured using the flow cytometer at 4C in the dark. 
Each experiment was performed in triplicate. 
 
Trans-well assay 
Seventy-two hours after transfection, the U2-OS 
cells were starved for 12 h, detached with trypsin, 
washed with PBS for twice, adjusted to 1 × 10
6
 
cells/mL and resuspended. Matrigel (BD Biosciences, 
San Jose, CA, USA) was dissolved at 4℃ overnight 
and diluted at 1:10 in serum-free DMEM on ice. Each 
well in the apical chamber was coated with 100 μL 
diluted Matrigel and allowed to stand for 2 h at 37℃, 
and further washed twice with serum-free DMEM for 
following experiments. The resuspended cells (50 μL) 
were added into the apical chamber wells, while  
600 μL complete medium supplemented with 10% 
FBS was added to the basolateral chamber and the 
Trans-well kits were cultured in at 37℃ with 5% CO2 
for 24 h. Then the Transwell kits were taken out and 
the cells on the inner side of the apical chamber were 
wiped away using cotton swabs, after which the 
invaded cells were fixed with formaldehyde for  
30 min at room temperature subjected to 20 min of 
crystal violet staining. Next, cells in each group were 
washed with clean water for 3 times and observed 
under a microscope with 6 fields randomly selected, 
and the average cell volume in each field was 
calculated. Cell migration assay was conducted at the 
same way as the invasion assay but rather than coated 
with Matrigel, the apical chamber was added with 100 
μL cell suspension instead. 
 
Statistical analysis 
Data were analyzed using SPSS 21.0 (IBM Corp. 
Armonk, NY, USA). Measurement data were expressed 
as mean ± standard deviation. Differences among 
multiple groups were compared using one-way analysis 
of variance (ANOVA) and Bonferroni correction was 




applied for pair comparisons after ANOVA. P was 
obtained from two-tailed test and P <0.05 was regarded 
as statistically significant. 
 
Results 
miRNA-9-5p was down-regulated while Gab2 was up-
regulated in osteosarcoma cells 
The miR-9-5p expression in normal human osteoblast 
cell hFOB and osteosarcoma cell lines U2-OS, 143B, 
MG63 and HOS was detected using RT-qPCR, which 
suggested that compared to the hFOB cell line, miR-9-5p 
presented a lowest expression in U2-OS cells  
(P <0.05) (Fig. 1A). Meanwhile, Gab2 expression in 
each group of cells was evaluated using Western blot 
analysis, which indicated that Gab2 expression was 
significantly elevated in U2-OS cells (P <0.05) (Fig. 1B).  
 
miRNA-9-3p negatively targeted Gab2 
The computer-based program (http://www. 
targetscan.org) predicted that miR-9-3p could bind to the 
3 UTR of Gab2 (Fig. 2A). Correspondingly, compared 
to the NC group, cells co-transfected with miR-9-5p 
and Gab2-WT presented significantly decreased 
luciferase activity (P <0.05), while those co-
transfected with miR-9-5p and Gab2-Mut presented 
no major difference (P >0.05) (Fig 2B). To further 
identify if miR-9-5p targets Gab2, U2-0S cells were 
delivered with miR-9-5p inhibitor and si-Gab2, after 
which the miR-9-5p expression was measured using 
RT-qPCR (Fig. 2C). The results showed that 
compared to the control group, the miR-9-5p 
expression showed no significant difference between 
the inhibitor NC and the si-Gab2 groups (P >0.05), 
while the miR-9-5p expression in the miR-9-5p 
inhibitor group was obviously reduced as compared to 
the inhibitor NC group (P <0.05). Moreover, 
compared to the si-Gab2 group, the expression of 
miR-9-5p in the miR-9-5p inhibitor + si-Gab2 group 
was down-regulated (P <0.05). Meanwhile, the Gab2 
protein level showed little difference between the 
control and inhibitor NC groups (P >0.05), while 
compared to the inhibitor NC group, the Gab2 protein 
level was markedly enhanced in the miR-9-5p 
inhibitor group but down-regulated in the si-Gab2 
 
 
Fig. 2 — miR-9-3p negatively targeted Gab2. Note: A-B, binding 
relation of miR-9-5p and Gab2 predicted using a computer-based 
bio-information system (http://www.targetscan.org) (A) and 
identified using dual luciferase reporter gene assay (B) *, 
compared to the miR-9-5p group, P <0.05; C, miR-9-5p 
expression in U2-0S cells assessed using RT-qPCR; D, Gab 
protein level in U2-0S cells detected using Western blot analysis; 
In panel C and D, *, compared to the control group, P <0.05, #, 
compared to the inhibitor NC group, P <0.05; $, compared to the 
miR-9-5p inhibitor group, P <0.05, &, compared to the si-Gab2 
group, P <0.05 
 
 
Fig. 1 — miR-9-5p was down-regulated while Gab2 was up-regulated in osteosarcoma cells. Note: A, miR-9-5p expression in osteoblast 
and osteosarcoma cells measured using RT-qPCR; B, protein level of Gab2 in osteoblast and osteosarcoma cells detected using Western 
blot analysis; *, compared to the hFOB cell line, P <0.05 




group (all P <0.05). Compared to the si-Gab2 group, 
the Gab2 protein expression was notably increased in 
the miR-9-5p inhibitor + si-Gab2 group (P <0.05) 
(Fig. 2D). These results demonstrated that all the 
transfections were successfully performed and miR-9-
5p could negatively mediate Gab2 expression. 
 
Down-regulated miRNA-9-5p promoted U2-OS proliferation 
but silenced Gab2 inhibited U2-OS proliferation 
Proliferation of U2-OS was measured via CCK-8 
method (Fig. 3). The results suggested that after 96 h of 
culture, cell proliferation was markedly increased in the 
miR-9-5p but declined in the si-Gab2 group compared to 
that in the inhibitor NC group (all P <0.05). Moreover, 
cell proliferation in the miR-9-5p inhibitor + si-Gab 
group was significantly reduced compared to the miR-9-
5p inhibitor group but elevated compared to the si-Gab2 
group (all P <0.05). These findings revealed that 
inhibited miR-9-5p could promote U2-OS cell 
proliferation but silenced Gab2 could suppress this 
proliferation. 
 
Down-regulated miRNA-9-5p inhibited cell cycle arrest and 
apoptosis of U2-OS cells while silenced Gab2 led to an 
opposite trend 
The flow cytometry results (Fig. 4A) suggested that 
the U2-OS cell apoptosis showed no notable difference 
between the control and inhibitor NC group (P >0.05). 
While compared to the inhibitor NC group, the apoptosis 
of U2-OS cell in the miR-9-5p inhibitor group was 
notably reduced but that in the si-Gab2 group was 
markedly enhanced (all P <0.05). Meanwhile, U2-OS 
cell apoptosis in the miR-9-5p inhibitor + si-Gab group 
was significantly increased compared to the miR-9-5p 
inhibitor group but decreased compared to the si-Gab2 
group (all P <0.05). Regarding the cell cycle of U2-OS 
cells, the flow cytometry results (Fig. 4B) 
demonstrated that the U2-OS cell cycle showed little 
significant difference between the control and 
inhibitor NC group (P >0.05). Compared to the 
inhibitor NC group, the ratio of U2-OS cells in the 
G0/G1 phase in the miR-9-5p inhibitor group was 
obviously reduced while that in the si-Gab2 group  
was markedly enhanced (all P <0.05). Meanwhile, 
U2-OS cell apoptosis in the miR-9-5p inhibitor + si-
Gab group was significantly increased compared to 
the miR-9-5p inhibitor group but decreased compared 
to the si-Gab2 group (all P <0.05). These findings 
demonstrated that lowly-expressed miR-9-5p could 
reduce the ratio of cells in the G0/G1 phase and 
inhibit apoptosis of U2-OS cells, while silenced 
Gab2 could lead to an opposite trend. 
 
Down-regulated miRNA-9-5p promoted U2-OS invasion and 
migration but silenced Gab2 reversed this trend 
Cell invasion and migration was measured using 
Trans-well assays (Fig. 5), and the results showed that 
cell invasion and migration presented little difference 
between the control and inhibitor NC groups (P >0.05). 
Compared to the inhibitor NC group, the invasive and 
migratory abilities of U2-OS cells were markedly 
enhanced in the miR-9-5p inhibitor group but decreased 
in the si-Gab2 group (all P <0.05). While the invasive 
and migratory abilities of U2-OS cells in the miR-9-5p 
inhibitor + si-Gab group were markedly reduced 
compared to the miR-9-5p inhibitor group but enhanced 
compared to the si-Gab2 group (all P <0.05).  
 
Down-regulated miRNA-9-5p elevated the expression of 
invasion- and migration-related factors 
MMP-2 and MMP-9 are well-known tumor invasion 
promoters. Here, our study explored the expression of 
these two factors in each group (Fig. 6A & B). The 
MMP-2 and MMP-9 expression showed no notable 
difference between the control and the inhibitor NC 
groups (all P >0.05), which was consistence with the 
Transwell assay results. Meanwhile, compared to the 
inhibitor NC group, the MMP-2 and MMP-9 expression 
was significantly elevated in the miR-9-5p inhibitor 
group while decreased in the si-Gab2 group (all  
P <0.05). Likewise, the MMP-2 and MMP-9 expression 
in the miR-9-5p inhibitor + si-Gab group was markedly 
reduced compared to the miR-9-5p inhibitor group but 
enhanced compared to the si-Gab2 group (all P <0.05). 
 
 
Fig. 3 — Down-regulated miR-9-5p promoted U2-OS 
proliferation but silenced Gab2 inhibited U2-OS proliferation. 
Note: A, cell proliferation in each group measured using CCK-8 
method; *, compared to the control group, P <0.05, #, compared to 
the inhibitor NC group, P <0.05; $, compared to the miR-9-5p 
inhibitor group, P <0.05, &, compared to the si-Gab2 group,  
P <0.05 





Osteosarcoma is the most prevalent bone primary 
malignancy in young people
24
. An intensive 
understanding of the initiation and development 
mechanisms of osteosarcoma is required for 
developing novel therapeutic options for 
osteosarcoma patients to enhance overall survival. To 
date, multiple miRNAs have been documented to be 
involved in osteosarcoma development
25
. Also, 
miRNA has been reported to potentially inhibit 
proliferation in some cancers via targeting GRB2
26,27
. 
Here, the current study investigated the role of 
miRNA-9-5p in osteosarcoma and found that it could 
inhibit the development of osteosarcoma cells 
including proliferation, invasion and resistance to 
death by negatively targeting Gab2. 
Initially, down-regulated miRNA-9-5p while up-
regulated Gab2 was found in osteosarcoma cells. In 
previous study, downregulated miR-9-5p by TGF-β1 
led to HSC activation, including cell proliferation,  
α-SMA and collagen expression, and this is indicative in 
many carcinomas
28
. Thus, its upregulation is critical to  
 
 
Fig. 4 — Down-regulated miR-9-5p inhibits cell cycle arrest and apoptosis of U2-OS cells while silenced Gab2 promoted cell apoptosis. 
Note: A, U2-OS cell apoptosis detected using flow cytometry; B, U2-OS cell cycle measured using flow cytometry; *, compared to the 
control group, P <0.05, #, compared to the inhibitor NC group, P <0.05; $, compared to the miR-9-5p inhibitor group, P <0.05, &, 
compared to the si-Gab2 group, P <0.05 







Fig. 5 — Down-regulated miR-9-5p promoted U2-OS cell invasion and migration but silenced Gab2 reversed this trend. Note: A, cell 
invasion and migration detected using Trans-well assays; B, analysis of the invasion and migration of each group of U2-OS cells; *, 
compared to the control group, P <0.05, #, compared to the inhibitor NC group, P <0.05; $, compared to the miR-9-5p inhibitor group,  




Fig. 6 — Down-regulated miR-9-5p elevated the MMP-2 and MMP-9 expression in U2-OS cells. Note: A, MMP-2 and MMP-9 mRNA 
expression detected using RT-qPCR; MMP-2 and MMP-9 protein levels determined using Western blot analysis; *, compared to the 
control group, P <0.05, #, compared to the inhibitor NC group, P <0.05; $, compared to the miR-9-5p inhibitor group, P <0.05, &, 
compared to the si-Gab2 group, P <0.05 





prevent and inhibit certain cancer cells. miRNA-9-5p 
has been reported as a tumor inhibitor in several cancers 
including osteosarcoma
6
. Meanwhile, miRNA-9-5p 
directly bound to the 3UTR of Gab2 according to bio-
information software prediction and dual luciferase 
reporter gene assay. Gab2 is a well-known tumor-related 




Findings from this study showed that down-regulated 
miRNA-9-5p led to enhanced U2-OS cell proliferation, 
invasion, migration and resistance to death, while 
silenced Gab2 led to a contrary tendency. It has been 
suggested that miRNA-9-5p suppresses growth and 
development of pancreatic cancer by targeting GOT1
29
. 
Meanwhile, miRNA-9-5p also has shown the tumor-
suppressive effect on papillary thyroid cancer via 
inhibiting cell proliferation and promoting cell 
apoptosis
30
. Likewise, in osteosarcoma, up-regulated 
miR-9-5p has been suggested to inhibit cell promotion 
and growth but promote cell cycle arrest in G0/G1 
period and cell apoptosis
6
. This also agrees with the 
findings of Yu et al.
28
, who reported that upregulated 
miR-9-5p effectively prevented liver fibrosis. Regarding 
Gab2, inhibited Gab2 expression has been found to 







. Similarly, studies by 
Wang et al. showed that silenced Gab2 was identified to 
decrease osteosarcoma cell invasion and migration
19
, 
and this agrees with the findings of our study. Moreover, 
our study showed that down-regulated miRNA-9-5p 
enhanced MMP-2 and MMP-9 expression in 
osteosarcoma cells. MMPs are well-known metastasis-
related factors. Up-regulation of miRNA-9-5p has been 
documented to reduce MMPs levels in osteoarthritis
33
. 
While Gab2 has been suggested to facilitate the 
metastasis and epithelial to mesenchymal transition  
by activating MMPs in colorectal cancer
34
. These  
results further provided evidence that down-regulated 
miRNA-9-5p could lead to osteosarcoma cell invasion 




To sum up, it can be concluded that miRNA-9-5p 
could inhibit osteosarcoma development by suppressing 
its malignant behaviors such as proliferation, invasion, 
migration and resistance to apoptosis via negatively 
targeting Gab2 expression. Thus, miRNA-9-5p might 
serve as a novel treating target for osteosarcoma. 
However, there might be several target genes of 
miRNA-9-5p while only Gab2 was included in the 
current study. More studies would be performed in this 
field to validate our findings and to develop more 
therapeutic options for osteosarcoma. 
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